Cme Group Inc.

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $102.30B
  • PE 29
  • Debt $3.42B
  • Cash $122.11B
  • EV -$16.39B
  • FCF $3.83B

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$3.58B
EBIT$4.67B
ROE13%
ROA3%
FCF$3.83B
Equity$27.03B
Growth Stability78%
PE28.57
PEG2.27
PB3.78
P/FCF26.74
P/S16.28
Price/Cash1.19
Debt/Equity0.13
Debt/FCF0.89
Net Margins57%
Op. Margins74%
Earnings CAGR7%
Sales Growth YoY10%
Sales Growth QoQ8%
Sales CAGR6%
FCF CAGR10%
Equity CAGR4%
Earnings Stability0.28
Earnings Growth YoY12%
Earnings Growth QoQ9%
Earnings CAGR 5Y13%
Sales CAGR 5Y6%
FCF CAGR 5Y11%
Equity CAGR 5Y0%
Earnings CAGR 3Y10%
Sales CAGR 3Y10%
FCF CAGR 3Y14%
Equity CAGR 3Y-1%
Market Cap$102.30B
Revenue$6.28B
Dividend Yield4%
Payout Ratio107%
Assets$157.83B
Total Debt$3.42B
Cash$122.11B
Shares Outstanding359.01M
EV-16.39B
Earnings Score12%
Moat Score73%
Safety Score95%
Final Score60%
Working Capital2.03B
Current Ratio1.02
Shares Growth 3y0%
Equity Growth QoQ2%
Equity Growth YoY-0%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

SEC Filings

Direct access to Cme Group Inc. (CME) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2025
    • 10-Q Mar 31
  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Cme Group Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Cme Group Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 7%
Stability 28%
loading chart...

Cme Group Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Cme Group Inc..

= $75B
012345678910TV
fcf$3.8B$4.2B$4.6B$5.1B$5.5B$6.1B$6.7B$7.3B$8B$8.8B$9.7B$97B
DCF$3.8B$3.8B$3.8B$3.8B$3.8B$3.8B$3.8B$3.8B$3.7B$3.7B$37B
Value$75B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins37%43%111%46%43%43%56%53%57%57%57%
ROA-3%3%4%4%2%2%2%3%3%3%
ROE-8%18%8%8%8%10%10%12%13%13%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF-1.371.271.891.541.371.511.161.010.950.89
Debt over Equity0.110.110.10.170.140.130.130.130.130.130.13
Growth Stability---86%84%78%100%100%100%100%78%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-8%1%18%13%0%-4%7%11%10%6%
Earnings YoY growth-23%165%-52%8%-1%24%2%20%9%13%
Equity YoY growth--1%10%16%1%1%4%-2%-1%-1%0%
FCF YoY growth-16%8%32%4%4%-10%30%14%6%11%